• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗疟药物及疟原虫脂肪酸代谢途径的药物靶点。

Antimalarial drugs and drug targets specific to fatty acid metabolic pathway of Plasmodium falciparum.

机构信息

Metabolic and Structural Biology Department, CSIR-Central Institute of Medicinal and Aromatic Plants, P.O. CIMAP, Kukrail Picnic Spot Road, Lucknow 226015, UP, India.

出版信息

Chem Biol Drug Des. 2012 Aug;80(2):155-72. doi: 10.1111/j.1747-0285.2012.01389.x. Epub 2012 May 28.

DOI:10.1111/j.1747-0285.2012.01389.x
PMID:22487082
Abstract

Plasmodium falciparum, a causitive agent of malaria, is the third most prevalent factor for mortility in the world. Falciparum malaria is an example of evolutionary and balancing selection. Because of mutation and natural selection, the parasite has developed resistance to most of the existing drugs. Under such circumstances, there is a growing need to develop new molecular targets in P. falciparum. A four membrane bound organelles called apicoplast, very much similar to that of chloroplast of plants, have been found in parasite. Therefore, the proteins involved in metabolic pathways of apicoplasts are important drug targets. Among the pathways in apicoplast, fatty acid biosynthetic pathway is the most important metabolic pathway in P. falciparum. Several studies have explored the role of different proteins involved in this pathway and antimalarial compounds against this target. In this review, we have studied the role of different proteins in fatty acid metabolism and designing, synthesis and evaluation of compounds against the targets identified in fatty acid metabolic pathway.

摘要

疟原虫(Plasmodium falciparum)是疟疾的病原体,是世界上第三大致死因素。恶性疟原虫是进化和平衡选择的一个例子。由于突变和自然选择,寄生虫对大多数现有药物产生了耐药性。在这种情况下,人们越来越需要在疟原虫中开发新的分子靶标。在寄生虫中发现了一种称为类质体的四个膜结合细胞器,非常类似于植物的叶绿体。因此,类质体代谢途径中涉及的蛋白质是重要的药物靶标。在类质体途径中,脂肪酸生物合成途径是疟原虫中最重要的代谢途径。已有多项研究探讨了该途径中不同蛋白质的作用以及针对该靶点的抗疟化合物。在这篇综述中,我们研究了脂肪酸代谢中不同蛋白质的作用,并设计、合成和评估了针对脂肪酸代谢途径中鉴定出的靶标的化合物。

相似文献

1
Antimalarial drugs and drug targets specific to fatty acid metabolic pathway of Plasmodium falciparum.抗疟药物及疟原虫脂肪酸代谢途径的药物靶点。
Chem Biol Drug Des. 2012 Aug;80(2):155-72. doi: 10.1111/j.1747-0285.2012.01389.x. Epub 2012 May 28.
2
Plasmodium falciparum: new molecular targets with potential for antimalarial drug development.恶性疟原虫:具有抗疟药物开发潜力的新分子靶标。
Expert Rev Anti Infect Ther. 2009 Nov;7(9):1087-98. doi: 10.1586/eri.09.93.
3
Helicases - feasible antimalarial drug target for Plasmodium falciparum.解旋酶——恶性疟原虫可行的抗疟药物靶点。
FEBS J. 2007 Sep;274(18):4699-704. doi: 10.1111/j.1742-4658.2007.06000.x.
4
Tropical infectious diseases: metabolic maps and functions of the Plasmodium falciparum apicoplast.热带传染病:恶性疟原虫顶质体的代谢图谱与功能
Nat Rev Microbiol. 2004 Mar;2(3):203-16. doi: 10.1038/nrmicro843.
5
[Transport proteins as drug targets in Plasmodium falciparum. New perspectives in the treatment of malaria].[疟原虫中的转运蛋白作为药物靶点。疟疾治疗的新视角]
Ugeskr Laeger. 2006 Mar 27;168(13):1314-7.
6
Antimalarial drug targets and drugs targeting dolichol metabolic pathway of Plasmodium falciparum.疟原虫达菲醇代谢途径的抗疟药物靶点和药物。
Curr Drug Targets. 2014 Apr;15(4):374-409. doi: 10.2174/13894501113149990169.
7
The apicoplast as an antimalarial drug target.顶质体作为抗疟药物靶点。
Drug Resist Updat. 2001 Jun;4(3):145-51. doi: 10.1054/drup.2001.0205.
8
Plasmodium kinases as targets for new-generation antimalarials.疟原虫激酶作为新一代抗疟药物的靶标。
Future Med Chem. 2012 Dec;4(18):2295-310. doi: 10.4155/fmc.12.183.
9
Is PfCRT a channel or a carrier? Two competing models explaining chloroquine resistance in Plasmodium falciparum.疟原虫氯喹抗性转运蛋白(PfCRT)是一种通道还是载体?两种相互竞争的模型解释恶性疟原虫对氯喹的抗性。
Trends Parasitol. 2007 Jul;23(7):332-9. doi: 10.1016/j.pt.2007.04.013. Epub 2007 May 10.
10
[Mechanism of action of antimalarials. Value of combined atovaquone/proguanil].[抗疟药的作用机制。阿托伐醌/氯胍联合用药的价值]
Med Trop (Mars). 2002;62(3):219-24.

引用本文的文献

1
Identifying Opportunity Targets in Gram-Negative Pathogens for Infectious Disease Mitigation.确定革兰氏阴性病原体中用于减轻传染病的机会靶点。
ACS Cent Sci. 2025 Jan 3;11(1):25-35. doi: 10.1021/acscentsci.4c01437. eCollection 2025 Jan 22.
2
In silico evaluation and in vitro growth inhibition of Plasmodium falciparum by natural amides and synthetic analogs.通过天然酰胺和合成类似物对恶性疟原虫进行计算机评估和体外生长抑制。
Parasitol Res. 2020 Jun;119(6):1879-1887. doi: 10.1007/s00436-020-06681-9. Epub 2020 May 8.
3
Does Plasmodium falciparum have an Achilles' heel?
恶性疟原虫有致命弱点吗?
Malar Chemother Control Elimin. 2014 Apr 5;3(1). doi: 10.4172/2090-2778.1000114.
4
In silico screening for Plasmodium falciparum enoyl-ACP reductase inhibitors.恶性疟原虫烯脂酰-ACP还原酶抑制剂的计算机筛选
J Comput Aided Mol Des. 2015 Jan;29(1):79-87. doi: 10.1007/s10822-014-9806-3. Epub 2014 Oct 25.
5
Celastrol inhibits Plasmodium falciparum enoyl-acyl carrier protein reductase.雷公藤红素抑制恶性疟原虫烯脂酰-酰基载体蛋白还原酶。
Bioorg Med Chem. 2014 Nov 1;22(21):6053-6061. doi: 10.1016/j.bmc.2014.09.002. Epub 2014 Sep 15.
6
Novel type II fatty acid biosynthesis (FAS II) inhibitors as multistage antimalarial agents.新型 II 型脂肪酸生物合成 (FAS II) 抑制剂作为多阶段抗疟药物。
ChemMedChem. 2013 Mar;8(3):442-61. doi: 10.1002/cmdc.201200407. Epub 2013 Jan 22.